Phase 3 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had poor sleep quality for at least 2 weeks, with a score of 5 or higher on a standard sleep quality questionnaire called the PSQI
- People who are able to communicate in English
- People who are mentally alert enough to answer questions clearly, as measured by a standard assessment tool (confirm with trial site)
- People who are willing and able to sign a written consent form
- People whose cancer specialist or the lead researcher has estimated they are likely to live for at least another year
- People who have no pain, or whose pain is well-controlled and stable — meaning pain is rated 4 or below on a standard symptom scale, or they have been on a steady dose of pain medication for at least 1 month
- People aged 18 years or older
- People who are willing to attend follow-up visits either in person or by video call, and who are able to complete the therapy sessions (either in person or online) within the state of Texas
Who may not be able to join:
- People who are currently taking prescription anti-inflammatory medications or steroids, unless those medications were used specifically to prevent side effects during or before cancer treatment (such as for nausea)
- People with a known history of certain mental health conditions (such as schizophrenia, bipolar disorder, or major depressive disorder), certain sleep disorders (such as sleep apnea, narcolepsy, or periodic limb movement disorder), obesity-related breathing problems during sleep, glaucoma, blindness (present from birth or acquired), significant cataracts or retinal disease, or people who regularly work night shifts
- People who score 21 or higher on an anxiety and depression questionnaire, or who are taking antidepressants — unless they have been on a stable dose of antidepressants for at least 1 month
- People who are currently taking sleep medications or stimulants, unless they have been on a stable dose of those medications for at least 1 month
- People who are taking certain types of medications, including a group called MAO inhibitors, tricyclic antidepressants, or blood thinners
- People who have spent 30 or more consecutive minutes in bright sunlight every day over the past month, or who have previously tried bright light therapy, melatonin-related treatments, or a type of talking therapy called CBT for sleep
- People whose doctor (the lead researcher) determines there is another medical reason that would make participation risky
- People taking part in the brain scan (MRI) part of the study who have any metal objects in their body (such as metal plates, certain dental braces, or a heart pacemaker), or who experience claustrophobia (fear of enclosed spaces)
- People who are pregnant, as recorded in their medical record
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sriram Yennu, MD, MD Anderson
Phone: 713-792-6085
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pittsburgh Sleep Quality Index (PSQI) questionnaires
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.